These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16284921)

  • 1. Population pharmacokinetic-pharmacodynamic modeling of subcutaneous and pulmonary insulin in rats.
    Gopalakrishnan M; Suarez S; Hickey AJ; Gobburu JV
    J Pharmacokinet Pharmacodyn; 2005 Aug; 32(3-4):485-500. PubMed ID: 16284921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facilitation of pulmonary insulin absorption by H-MAP: pharmacokinetics and pharmacodynamics in rats.
    Suarez S; Garcia-Contreras L; Sarubbi D; Flanders E; O'Toole D; Smart J; Hickey AJ
    Pharm Res; 2001 Dec; 18(12):1677-84. PubMed ID: 11785686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of pharmacokinetic and pharmacodynamic properties of single-dose oral insulin spray and subcutaneous insulin injection in healthy subjects using the euglycemic clamp technique.
    Cernea S; Kidron M; Wohlgelernter J; Modi P; Raz I
    Clin Ther; 2004 Dec; 26(12):2084-91. PubMed ID: 15823772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetic model of human insulin following different routes of administration.
    Potocka E; Baughman RA; Derendorf H
    J Clin Pharmacol; 2011 Jul; 51(7):1015-24. PubMed ID: 20940337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. State of insulin self-association does not affect its absorption from the pulmonary route.
    Hussain A; Ahsan F
    Eur J Pharm Sci; 2005 Jun; 25(2-3):289-98. PubMed ID: 15911225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of pulmonary insulin delivery in diabetic rats: use of a model-based approach in the evaluation of insulin powder formulations.
    Amidi M; Krudys KM; Snel CJ; Crommelin DJ; Della Pasqua OE; Hennink WE; Jiskoot W
    J Control Release; 2008 May; 127(3):257-66. PubMed ID: 18353483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of absorption promoters on pulmonary insulin bioactivity.
    Kumar TM; Misra A
    AAPS PharmSciTech; 2003; 4(2):E15. PubMed ID: 12916897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-response relationship of an oral insulin spray in six patients with type 1 diabetes: a single-center, randomized, single-blind, 5-way crossover study.
    Cernea S; Kidron M; Wohlgelernter J; Raz I
    Clin Ther; 2005 Oct; 27(10):1562-70. PubMed ID: 16330292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic-pharmacodynamic modelling of insulin: comparison of indirect pharmacodynamic response with effect-compartment link models.
    Lin S; Chien YW
    J Pharm Pharmacol; 2002 Jun; 54(6):791-800. PubMed ID: 12078995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic-pharmacodynamic modelling of human insulin: validity of pharmacological availability as a substitute for extent of bioavailability.
    Miyazaki M; Mukai H; Iwanaga K; Morimoto K; Kakemi M
    J Pharm Pharmacol; 2001 Sep; 53(9):1235-46. PubMed ID: 11578106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of inhaled recombinant human insulin dry powders: pharmacokinetics, pharmacodynamics and 14-day inhalation.
    He J; Zhang G; Zhang Q; Chen J; Zhang Y; An X; Wang P; Xie S; Fang F; Zheng J; Tang Y; Zhu J; Yu Y; Chen X; Lu Y
    J Pharm Pharmacol; 2019 Feb; 71(2):176-184. PubMed ID: 30324757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of novel particles as pulmonary delivery systems for insulin in rats.
    Garcia-Contreras L; Morçöl T; Bell SJ; Hickey AJ
    AAPS PharmSci; 2003; 5(2):E9. PubMed ID: 12866936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel hormonal delivery method using the ink-jet technology: application to pulmonary insulin therapies.
    Nemoto M; Hiki Y; Shimada K; Nakai N; Fujimoto K; Inoue S; Sakurada N; Kaneko H; Sugita M; Okabe M; Sasaki T
    Diabetes Technol Ther; 2011 May; 13(5):509-17. PubMed ID: 21406017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic/pharmacodynamic modeling of glucose clamp effects of inhaled and subcutaneous insulin in healthy volunteers and diabetic patients.
    Landersdorfer CB; Jusko WJ
    Drug Metab Pharmacokinet; 2010; 25(5):418-29. PubMed ID: 20924141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin disposition in the lung following oral inhalation in humans : a meta-analysis of its pharmacokinetics.
    Sakagami M
    Clin Pharmacokinet; 2004; 43(8):539-52. PubMed ID: 15170368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technosphere/Insulin--a new approach for effective delivery of human insulin via the pulmonary route.
    Pfützner A; Mann AE; Steiner SS
    Diabetes Technol Ther; 2002; 4(5):589-94. PubMed ID: 12450439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time-action profile of an oral enteric insulin formulation in healthy Chinese volunteers.
    Li J; Wang Y; Han L; Sun X; Yu H; Yu Y
    Clin Ther; 2012 Dec; 34(12):2333-8. PubMed ID: 23195963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The preparation and application of pulmonary surfactant nanoparticles as absorption enhancers in insulin dry powder delivery.
    Zhang Y; Zhu J; Tang Y; Chen X; Yang Y
    Drug Dev Ind Pharm; 2009 Sep; 35(9):1059-65. PubMed ID: 19640250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AIR insulin capsules of different dose strengths may be combined to yield equivalent pharmacokinetics and glucodynamics.
    de la Peña A; Seger M; Rave K; Heinemann L; Silverman B; Muchmore DB
    Diabetes Technol Ther; 2009 Sep; 11 Suppl 2():S75-80. PubMed ID: 19772452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deposition of insulin powders for inhalation in vitro and pharmacodynamic evaluation of absorption promoters in rats.
    Yang DB; Zhu JB; Zhu H; Zhang XS
    Yao Xue Xue Bao; 2005 Dec; 40(12):1069-74. PubMed ID: 16496667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.